Hints and tips:
...Microsoft is selling cloud services to hospitals and drug companies, while Facebook is offering tools for users to manage screenings....
...A version of this article was first published by the Nikkei Asian Review on July 5, 2019. ©201 Nikkei Inc. All rights reserved....
...Doctors Foster and Smith also advertise a pet drug that has reported potential for human abuse....
...(Bloomberg, LA Times, Guardian) China breakthrough Chi-Med — backed by Li Ka-shing, Hong Kong’s richest man — is on the brink of becoming the first Chinese company to get US approval for a new cancer drug...
...Google parent backs drug developer fund with $300m The life sciences division of Google’s parent company has invested in a $300m biotech fund, marking its biggest foray into the realm of drug development...
...Gradually, however, China MediTech, or Chi-Med, began building its own R&D capabilities in partnership with western drugmakers including Eli Lilly and AstraZeneca....
...- Game of Thrones Econ Twitter at number nine? Really now Nick. - There is no great dental stagnation. - Further, further reading....
...“Individual companies though could experience major shifts, especially if certain deductions would be removed like R&D tax credits which benefit technology, biotech, drug and med-tech companies the most,...
...Events in Baltimore, in the Med and on Airbnb raise the question: when and how does the majority decide to act on structural racism? For minorities, structural racism is everyday....
...(WaPo) In the news China’s Hunger Games Dalian Wanda seeks a controlling stake in Lions Gate Entertainment, maker of Mad Men and The Hunger Games, while Fosun ups its bid for Club Med....
...nestle.com/investors Pet meds More accessible to investors is the animal pharmaceutical market, estimated to be worth $23bn in 2013 by consultancy Vetnosis....
...His examples include a freedom of information request on one drug that was so redacted that nothing was left but the letterhead....
...aimed at producing generic drugs for the Chinese market....
...“Q-Med is a strategic asset for us.”...
...“The Club Med deal is a good example of what this fund can do – investing in global brands that can do better with Fosun’s help by expanding in China,” he said....
...AstraZeneca cemented such a move with its purchase of biological medicine-focused companies such as CAT and MedImmune....
...The US Drug Enforcement Administration and the Food and Drug Administration are concerned that the practice is continuing despite the deaths of consumers who ordered drugs without examination by a doctor...
...The drug is no longer protected by a patent from Pfizer, and is also sold by at least two other generic manufacturers, Lupin of India and Med Shine Pharma of China....
...Others with adult stem cell products in trials include Aastrom Biosciences, Cytori Therapeutics and StemCells Inc....
...Companies such as Chi-Med in China and Nicholas Piramal in India developed some of their more promising leads from natural compounds that have no link to historical treatments....
...Drug company AstraZeneca, off 4.1 per cent at £28.32, was the biggest FTSE 100 faller after surprising the market with a $15.6bn (£7.8bn) deal to buy Med-Immune, a US biotech company that made profits of...
...Alliance Boots, the drug distribution and retail company, is to enter the Chinese market through a joint venture with Guangzhou Pharmaceuticals Corporation, the country’s third largest pharmaceutical wholesaler...
...The UK drug distribution and retail company’s joint venture in China is in fact two new ventures....
International Edition